- Home
- ARTW vs AIMD Comparison
ARTW vs AIMD Comparison
Compare ARTW & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- AIMD
- Stock Information
- Founded
- ARTW 1956
- AIMD 1984
- Country
- ARTW United States
- AIMD United States
- Employees
- ARTW N/A
- AIMD N/A
- Industry
- ARTW Industrial Machinery/Components
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- AIMD Health Care
- Exchange
- ARTW Nasdaq
- AIMD Nasdaq
- Market Cap
- ARTW 8.6M
- AIMD 8.5M
- IPO Year
- ARTW N/A
- AIMD N/A
- Fundamental
- Price
- ARTW $1.68
- AIMD $0.62
- Analyst Decision
- ARTW
- AIMD
- Analyst Count
- ARTW 0
- AIMD 0
- Target Price
- ARTW N/A
- AIMD N/A
- AVG Volume (30 Days)
- ARTW 32.5K
- AIMD 227.7K
- Earning Date
- ARTW 02-11-2025
- AIMD 03-07-2025
- Dividend Yield
- ARTW N/A
- AIMD N/A
- EPS Growth
- ARTW 17.02
- AIMD N/A
- EPS
- ARTW 0.06
- AIMD N/A
- Revenue
- ARTW $24,499,371.00
- AIMD $40,633.00
- Revenue This Year
- ARTW N/A
- AIMD N/A
- Revenue Next Year
- ARTW N/A
- AIMD N/A
- P/E Ratio
- ARTW $27.78
- AIMD N/A
- Revenue Growth
- ARTW N/A
- AIMD N/A
- 52 Week Low
- ARTW $1.33
- AIMD $0.40
- 52 Week High
- ARTW $4.15
- AIMD $3.10
- Technical
- Relative Strength Index (RSI)
- ARTW 45.62
- AIMD 47.20
- Support Level
- ARTW $1.61
- AIMD $0.56
- Resistance Level
- ARTW $1.77
- AIMD $0.77
- Average True Range (ATR)
- ARTW 0.11
- AIMD 0.06
- MACD
- ARTW -0.00
- AIMD -0.01
- Stochastic Oscillator
- ARTW 25.81
- AIMD 28.67
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.